← Leaderboards
Ahmed Osama Gaber
University Of Tennessee Health Sci Ctr
$1,595,876
Attributed
$1,595,876
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $216K · FY2005–07$250K$187.5K$125K$62.5K$0
'05
'06
'07
Funding mix
By agency
NIH$2,590,877 · 5
By mechanism
U42$1,545,977 · 3
R01$828,900 · 1
R34$216,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Tennessee Health Sci Ctr
Same institution · by research overlap
- Ivan C Gerling$3,519,953
- Donna K. Hathaway$4,924,717
- Isaac O. Donkor$897,843
- Malak Y.s. Kotb$5,291,499
- Omaima M Sabek$0
Others in their field
Top investigators on “Insulin Dependent Diabetes Mellitus”
- Jeffrey P Krischer · University Of South Florida$604,626,891
- John M Lachin · George Washington University$152,707,971
- David M Nathan · Massachusetts Institute Of Technology$142,449,293
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$108,827,660
- Marinella Temprosa · George Washington University$65,495,338
- Rose A Gubitosi-Klug · Case Western Reserve University$65,228,131
Research focus
Insulin Dependent Diabetes MellitusPancreatic Islet TransplantationDiabetes Mellitus TherapyT LymphocyteNod MouseTissue /Cell CultureNonhuman Therapy EvaluationGene ExpressionGenetic ManipulationPancreatic Islet FunctionHuman TissueInflammationMacrophageMonocyteCd3 MoleculeCd34 MoleculeDisease /Disorder ModelExtracellular Matrix ProteinsAngiogenesisHomologous TransplantationHematopoietic Stem CellsGene TherapyScid MouseTransforming Growth Factors
Grant awards (10)
Effect of Dietary Supplements in African American Kidney Transplant Recipients$216,000
R34 · FY2007 · AI · contact PI
OPTIMIZATION ON ISLET ISOLATION: TYPE 1 DIABETES: TRANSPLANTATION$40,000
U42 · FY2005 · RR
IMPACT OF STANDARDIZATION AND PROCEDURE OPTIMIZATION ON*$40,000
U42 · FY2005 · RR
OPTIMIZATION ON ISLET ISOLATION: TYPE 1 DIABETES: TRANSPLANTATION$510,976
U42 · FY2004 · RR
ENHANCEMENT OF HUMAN ISLET ENGRAFTMENT BY GENE THERAPY$214,500
R01 · FY2003 · DK
IMPACT OF STANDARDIZATION AND PROCEDURE OPTIMIZATION ON*$200,001
U42 · FY2003 · RR
ENHANCEMENT OF HUMAN ISLET ENGRAFTMENT BY GENE THERAPY$214,500
R01 · FY2002 · DK
STANDARDIZATION AND PROCEDURE ON ISLET ISOLATION$755,000
U42 · FY2001 · RR
ENHANCEMENT OF HUMAN ISLET ENGRAFTMENT BY GENE THERAPY$214,500
R01 · FY2001 · DK
ENHANCEMENT OF HUMAN ISLET ENGRAFTMENT BY GENE THERAPY$185,400
R01 · FY2000 · DK